GlaxoSmithKline Czech Republic - Non-Current Assets

GlaxoSmithKline CR`s Non-Current Assets reached 10.1 CZK mil in 2017. This is 37.4 % less than in the previous year.

$1.99

Buy Non-Current Assets data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             6.77 5.13 4.91 2.67 1.43    
Bayer Czech Republic CZK mil ... ... ...                 70.6 30.5 17.1 15.2 16.1    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 41.0 57.7 47.5 33.7 18.8    
Merck Czech Republic CZK mil ... ...                   10.1 9.11 8.11 5.62 6.32    
Novartis Czech Republic CZK mil                       12.0 23.4 34.3 34.3 55.3    
Pfizer Czech Republic CZK mil ... ...                   16.5 9.46 7.30 99.1 197    
Roche Czech Republic CZK mil ... ... ...                 329 354 338 334 319   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               46.9 51.1 45.0 36.7 34.3    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 3.08 4.16 6.95 7.98    
Walmark CZK mil ... ... ...                 700 621 794 747 1,156